X0202 SCHEDULE 13G/A 0000935836-25-000689 0001105806 XXXXXXXX LIVE 4 Common Stock 03/31/2026 0001561921 TELA Bio, Inc. 872381108 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355 Rule 13d-1(c) Lytton, Laurence W. X1 2442341.00 0.00 2442341.00 0.00 2442341.00 N 5.5 IN The percentages reported in this Schedule 13G are based on 44,740,371 shares of Common Stock outstanding as of March 16, 2026, as reported in the Form 10-K filed by the Issuer for the fiscal year ended December 31, 2025. TELA Bio, Inc. 1 Great Valley Parkway, Suite 24, Malvern, PA 19355 Laurence W. Lytton 467 Central Park West New York, NY 10025 United States Y 2,442,341 5.5% 2,442,341 0 2,442,341 0 Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Lytton, Laurence W. /s/ Laurence W. Lytton 05/15/2026